Thrombotargets Corporation and Dr. Cam Patterson to Create a Joint Venture

Published: Jul 03, 2007

Durham, NC July, 3rd, 2007 -- Thrombotargets Corporation and Dr. Cam Patterson have signed a Memorandum of Intent for the establishment of a Thrombosis and Hemostasis specialised CRO that will provide new drug discovery services based on both university and Thrombotargets proprietary technologies.

Back to news